Tsuneji Suzuki
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 5
- Chemical Synthesis and Analysis 2
- Histone Deacetylase Inhibitors Research 2
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 5
- Organic Chemistry top 10%
- Oxidative Organic Chemistry Reactions 3
- Physiology top 10%
-
- Microbial Natural Products and Biosynthesis 3
-
- Copper Interconnects and Reliability 3
-
- Bioactive Compounds and Antitumor Agents 2
Tsuneji Suzuki
18 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Biology 995
- Oncology 353
- Organic Chemistry 302
- Physiology 33
- Biotechnology 43
Countries citing papers authored by Tsuneji Suzuki
This map shows the geographic impact of Tsuneji Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuneji Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuneji Suzuki more than expected).
Fields of papers citing papers by Tsuneji Suzuki
This network shows the impact of papers produced by Tsuneji Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuneji Suzuki. The network helps show where Tsuneji Suzuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tsuneji Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 8 | |
| 2 | 2014 | 1 | |
| 3 | 2012 | 1 | |
| 4 | Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. | 2002 | 114 |
| 5 | 1999 | 235 | |
| 6 | 1999 | 7 | |
| 7 | A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumorsbreakdown → | 1999 | 602 |
| 8 | 1997 | 81 | |
| 9 | 1995 | 55 | |
| 10 | 1995 | 1 | |
| 11 | Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073. | 1991 | 39 |
| 12 | 1989 | 21 | |
| 13 | 1985 | 53 | |
| 14 | 1985 | 9 | |
| 15 | 1984 | 4 | |
| 16 | 1984 | 6 | |
| 17 | 1984 | 4 | |
| 18 | 1983 | 49 |
About Tsuneji Suzuki
Tsuneji Suzuki is a scholar working on Toxicology, Pharmacology and Oncology, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers), Microbial Natural Products and Biosynthesis (3 papers), Copper Interconnects and Reliability (3 papers), Oxidative Organic Chemistry Reactions (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Chemical Synthesis and Analysis (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Molecular Biology (995 citations), Oncology (353 citations) and Organic Chemistry (302 citations). Tsuneji Suzuki has collaborated with scholars based in Japan and Germany. Frequent co-authors include Takashi Tsuruo, Osamu Nakanishi, Akiko Saito, Tomoyuki Ando, Takashi Yamashita, Nobuyuki Fukazawa, Wakao Sato, Masanori Yamaura, Juji Yoshimura and Hironobu Hashimoto. Their work appears in journals such as Proceedings of the National Academy of Sciences, ACS Applied Materials & Interfaces and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.